Emma Rousseau

626 total citations
13 papers, 263 citations indexed

About

Emma Rousseau is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Emma Rousseau has authored 13 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Genetics. Recurrent topics in Emma Rousseau's work include Protein Degradation and Inhibitors (4 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer Diagnosis and Treatment (2 papers). Emma Rousseau is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer Diagnosis and Treatment (2 papers). Emma Rousseau collaborates with scholars based in United States and China. Emma Rousseau's co-authors include Monica Andreoli, Mark Bookbinder, John Houston, Ryan R. Willard, Yimin Qian, I Taylor, Jennifer Pizzano, Gregory Cadelina, Janette E. Bradley and Hali Wang and has published in prestigious journals such as Blood, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Emma Rousseau

13 papers receiving 256 citations

Peers

Emma Rousseau
Emine Gulsen Gunes United States
Zachary Crees United States
Chaitanya R. Badwe United States
Justine Clark United States
Junichi Matsuo Singapore
Emma Rousseau
Citations per year, relative to Emma Rousseau Emma Rousseau (= 1×) peers Alfredo Zito

Countries citing papers authored by Emma Rousseau

Since Specialization
Citations

This map shows the geographic impact of Emma Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Rousseau more than expected).

Fields of papers citing papers by Emma Rousseau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Rousseau. The network helps show where Emma Rousseau may publish in the future.

Co-authorship network of co-authors of Emma Rousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Rousseau. A scholar is included among the top collaborators of Emma Rousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Rousseau. Emma Rousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Levy, Elizabeth S., An D. Nguyen, Donglu Zhang, et al.. (2023). Development of Liposome Systems for Enhancing the PK Properties of Bivalent PROTACs. Pharmaceutics. 15(8). 2098–2098. 12 indexed citations
2.
Snyder, Lawrence B., John J. Flanagan, Yimin Qian, et al.. (2021). Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer. Cancer Research. 81(13_Supplement). 44–44. 74 indexed citations
3.
Qian, Yimin, Monica Andreoli, Mark Bookbinder, et al.. (2019). Abstract P5-04-18: ARV-471, an oral estrogen receptor PROTAC degrader for breast cancer. Cancer Research. 79(4_Supplement). P5–4. 106 indexed citations
4.
Clarke, Astrid, Emma Rousseau, Kelly Wang, et al.. (2018). Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis. Thrombosis Research. 170. 109–118. 10 indexed citations
5.
Qian, Yimin, Monica Andreoli, Mark Bookbinder, et al.. (2018). Abstract P4-04-04: Identification and development of oral estrogen receptor PROTAC degraders for breast cancer. Cancer Research. 78(4_Supplement). P4–4. 2 indexed citations
8.
Rousseau, Emma, et al.. (2010). RGD-dependent binding of TP508 to integrin αvβ3 mediates cell adhesion and induction of nitric oxide. Thrombosis and Haemostasis. 104(7). 172–182. 3 indexed citations
9.
Li, Xinmin, Hali Wang, Edward Touma, et al.. (2007). TP508 accelerates fracture repair by promoting cell growth over cell death. Biochemical and Biophysical Research Communications. 364(1). 187–193. 22 indexed citations
10.
Li, Xinmin, Hali Wang, Edward Touma, et al.. (2006). Genetic network and pathway analysis of differentially expressed proteins during critical cellular events in fracture repair. Journal of Cellular Biochemistry. 100(2). 527–543. 19 indexed citations
11.
Rousseau, Emma & Elliott S. Goldstein. (2001). The gene structure of the Drosophila melanogaster homolog of the human proto-oncogene fos. Gene. 272(1-2). 315–322. 4 indexed citations
12.
Rousseau, Emma, et al.. (1977). [Considerations relating to multiple primary carcinomas of the urinary tract (author's transl)].. PubMed. 82(7-8). 621–6. 2 indexed citations
13.
Rousseau, Emma, et al.. (1976). [Multiple primary urinary cancers triple cancers].. PubMed. 105(9). 1351–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026